Filing Details
- Accession Number:
- 0001104659-17-034708
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-24 06:07:46
- Reporting Period:
- 2017-05-19
- Filing Date:
- 2017-05-24
- Accepted Time:
- 2017-05-24 06:07:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1660719 | Aralez Pharmaceuticals Inc. | ARLZ | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1376960 | Jason Aryeh | C/O Aralez Pharmaceuticals Inc., 7100 West Credit Avenue, Suite 101 Mississauga A6 L5N 0E4 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares, Without Par Value | Disposition | 2017-05-19 | 51,041 | $1.56 | 337,644 | No | 4 | S | Indirect | By JALAA Equities, LP |
Common Shares, Without Par Value | Disposition | 2017-05-22 | 233,468 | $1.42 | 104,176 | No | 4 | S | Indirect | By JALAA Equities, LP |
Common Shares, Without Par Value | Disposition | 2017-05-23 | 104,176 | $1.41 | 0 | No | 4 | S | Indirect | By JALAA Equities, LP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By JALAA Equities, LP |
No | 4 | S | Indirect | By JALAA Equities, LP |
No | 4 | S | Indirect | By JALAA Equities, LP |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Shares, Without Par Value | 15,000 | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $1.50 to $1.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Includes 45,469 shares issued in connection with a previously exercised warrant.
- Securities are owned by JALAA Equities, LP, of which the Reporting Person is the general partner. By reason of the provisions of Rule 16a-1 under the Securities Exchange Act of 1934, as amended, the Reporting Person may be deemed to be the beneficial owner of the securities owned by JALAA Equities, LP.
- This transaction was executed in multiple trades at prices ranging from $1.40 to $1.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $1.40 to $1.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.